NR546 Psychopharmacology Midterm Exam (2026/2027)
Comprehensive Assessment
2026-2027 | Total Questions: 100 | 100% VERIFIED
Introduction
This comprehensive assessment measures the core knowledge required of advanced
nursing candidates preparing for the NR546 Psychopharmacology midterm examination.
The assessment spans nine domains: Foundational Psychopharmacokinetics and
Pharmacodynamics; Neurotransmitter Systems and Receptor Targets; Antidepressant
Therapies and Side Effect Profiles; Antipsychotic Medications and Metabolic Monitoring;
Anxiolytics and Hypnotics; Mood Stabilizers; Psychostimulants and ADHD Management;
Substance Use Disorder Pharmacotherapy; and Special Populations. Each question tests a
distinct sub-topic mapped to the official NR546 blueprint, requiring applied professional
judgment, receptor-level reasoning, and safe prescribing decisions rather than simple recall.
Mastery of this material demonstrates readiness for academic progression and supports
safe, evidence-based advanced psychiatric nursing clinical execution.
Question 1. Bioavailability is best defined as:
A. The total quantity of tablet that dissolves in the stomach acid
B. The fraction of an administered dose that reaches systemic circulation in unchanged,
active form
C. The rate at which the kidney excretes the parent compound
D. The percentage of drug destroyed in the toilet water
Correct Answer: B — The fraction of an administered dose that reaches systemic
circulation in unchanged, active form
Rationale: Bioavailability quantifies active drug reaching the blood, shaped by
absorption and first-pass metabolism. Gastric dissolution, renal excretion rates, and the
humorous last option do not define it.
Question 2. A client drinks large quantities of grapefruit juice while taking buspirone and
develops exaggerated side effects. The mechanism is:
A. Inhibition of intestinal CYP3A4, reducing presystemic metabolism and raising plasma
levels
B. Induction of CYP2D6, accelerating drug clearance
C. Direct binding of buspirone to juice fiber
D. Stimulation of renal tubular reabsorption of the drug
Correct Answer: A — Inhibition of intestinal CYP3A4, reducing presystemic
metabolism and raising plasma levels
Rationale: Grapefruit juice inhibits intestinal CYP3A4, so substrates such as buspirone,
carbamazepine, and lurasidone reach circulation at higher levels. Induction, fiber
binding, and tubular reabsorption misstate the interaction.
,Question 3. A client stabilized on imipramine begins fluoxetine and develops dry mouth,
confusion, and widened QRS complexes. The mechanism is:
A. Induction of CYP3A4 by fluoxetine, lowering imipramine levels
B. Enhanced renal excretion of the tricyclic
C. CYP2D6 inhibition by fluoxetine, causing tricyclic accumulation
D. Displacement of imipramine from imipramine receptors only
Correct Answer: C — CYP2D6 inhibition by fluoxetine, causing tricyclic
accumulation
Rationale: Fluoxetine potently inhibits CYP2D6, so tricyclics accumulate toward
anticholinergic and cardiac toxicity. Induction, enhanced excretion, and receptor-only
effects misrepresent the pharmacokinetic cause.
Question 4. First-order elimination kinetics means a drug is cleared:
A. As a constant amount or milligram quantity per unit time
B. Completely within one hour
C. As a constant fraction or percentage per unit time
D. Only during daylight hours
Correct Answer: C — As a constant fraction or percentage per unit time
Rationale: First-order processes remove a fixed percentage per hour, so clearance
slows as levels fall; most psychotropics follow this pattern. Constant-amount removal
defines zero-order saturation kinetics.
Question 5. A highly lipophilic psychotropic with a large volume of distribution is:
A. Easily cleared by dialysis from the plasma
B. Unable to leave the bloodstream
C. Always safe in overdose without monitoring
D. Poorly removed by hemodialysis because most drug resides in tissues, not plasma
Correct Answer: D — Poorly removed by hemodialysis because most drug resides
in tissues, not plasma
Rationale: High tissue partitioning keeps plasma concentrations low, so dialysis
removes little drug in overdose. Dialyzability, blood confinement, and overdose safety
are false.
Question 6. The elimination half-life of a medication is the time required for:
A. Total body drug stores to fall to zero
B. The drug to reach its site of action
C. Plasma concentration to decrease by 50 percent
D. Absorption to begin in the small intestine
Correct Answer: C — Plasma concentration to decrease by 50 percent
Rationale: Half-life measures the 50 percent plasma decline used to time dosing and
predict steady state. Zero body burden, action-site delivery, and absorption onset
misstate the term.
, Question 7. A loading dose is prescribed for a medication with a long half-life in order to:
A. Reduce the total daily dose requirement permanently
B. Skip the maintenance phase entirely
C. Achieve therapeutic plasma concentrations rapidly rather than waiting several half-
lives
D. Eliminate the need for any monitoring
Correct Answer: C — Achieve therapeutic plasma concentrations rapidly rather
than waiting several half-lives
Rationale: A loading dose fills the volume of distribution so therapeutic levels appear
on day one, particularly valuable when the half-life is long. It does not replace
maintenance dosing or monitoring.
Question 8. A partial agonist at a receptor is distinguished by:
A. Producing the largest possible response at any occupancy
B. Blocking the receptor without any intrinsic activity
C. Accelerating receptor degradation permanently
D. Producing a submaximal response even when occupying all available receptors
Correct Answer: D — Producing a submaximal response even when occupying all
available receptors
Rationale: Partial agonists have intrinsic activity with a ceiling below full agonists,
improving safety in overdose or excess. Full agonist, pure antagonist, and degradative
labels misstate the pharmacology.
Question 9. Naloxone reverses opioid effects by acting as:
A. A full agonist that deepens sedation
B. A partial agonist with a high ceiling
C. A competitive antagonist that displaces agonists from mu receptors without intrinsic
activity
D. An enzyme that metabolizes all opioids instantly
Correct Answer: C — A competitive antagonist that displaces agonists from mu
receptors without intrinsic activity
Rationale: Naloxone competes for mu receptors, and its lack of intrinsic activity
reverses respiratory depression. Agonist and partial agonist labels reverse its action,
and it is not an enzyme.
Question 10. After months of continuous exposure to a receptor agonist, the typical
adaptive change is:
A. Upregulation and supersensitivity, amplifying the drug effect
B. Permanent destruction of the receptor gene
C. Downregulation or desensitization of receptors, reducing drug effect over time
D. No change whatsoever in receptor density
Comprehensive Assessment
2026-2027 | Total Questions: 100 | 100% VERIFIED
Introduction
This comprehensive assessment measures the core knowledge required of advanced
nursing candidates preparing for the NR546 Psychopharmacology midterm examination.
The assessment spans nine domains: Foundational Psychopharmacokinetics and
Pharmacodynamics; Neurotransmitter Systems and Receptor Targets; Antidepressant
Therapies and Side Effect Profiles; Antipsychotic Medications and Metabolic Monitoring;
Anxiolytics and Hypnotics; Mood Stabilizers; Psychostimulants and ADHD Management;
Substance Use Disorder Pharmacotherapy; and Special Populations. Each question tests a
distinct sub-topic mapped to the official NR546 blueprint, requiring applied professional
judgment, receptor-level reasoning, and safe prescribing decisions rather than simple recall.
Mastery of this material demonstrates readiness for academic progression and supports
safe, evidence-based advanced psychiatric nursing clinical execution.
Question 1. Bioavailability is best defined as:
A. The total quantity of tablet that dissolves in the stomach acid
B. The fraction of an administered dose that reaches systemic circulation in unchanged,
active form
C. The rate at which the kidney excretes the parent compound
D. The percentage of drug destroyed in the toilet water
Correct Answer: B — The fraction of an administered dose that reaches systemic
circulation in unchanged, active form
Rationale: Bioavailability quantifies active drug reaching the blood, shaped by
absorption and first-pass metabolism. Gastric dissolution, renal excretion rates, and the
humorous last option do not define it.
Question 2. A client drinks large quantities of grapefruit juice while taking buspirone and
develops exaggerated side effects. The mechanism is:
A. Inhibition of intestinal CYP3A4, reducing presystemic metabolism and raising plasma
levels
B. Induction of CYP2D6, accelerating drug clearance
C. Direct binding of buspirone to juice fiber
D. Stimulation of renal tubular reabsorption of the drug
Correct Answer: A — Inhibition of intestinal CYP3A4, reducing presystemic
metabolism and raising plasma levels
Rationale: Grapefruit juice inhibits intestinal CYP3A4, so substrates such as buspirone,
carbamazepine, and lurasidone reach circulation at higher levels. Induction, fiber
binding, and tubular reabsorption misstate the interaction.
,Question 3. A client stabilized on imipramine begins fluoxetine and develops dry mouth,
confusion, and widened QRS complexes. The mechanism is:
A. Induction of CYP3A4 by fluoxetine, lowering imipramine levels
B. Enhanced renal excretion of the tricyclic
C. CYP2D6 inhibition by fluoxetine, causing tricyclic accumulation
D. Displacement of imipramine from imipramine receptors only
Correct Answer: C — CYP2D6 inhibition by fluoxetine, causing tricyclic
accumulation
Rationale: Fluoxetine potently inhibits CYP2D6, so tricyclics accumulate toward
anticholinergic and cardiac toxicity. Induction, enhanced excretion, and receptor-only
effects misrepresent the pharmacokinetic cause.
Question 4. First-order elimination kinetics means a drug is cleared:
A. As a constant amount or milligram quantity per unit time
B. Completely within one hour
C. As a constant fraction or percentage per unit time
D. Only during daylight hours
Correct Answer: C — As a constant fraction or percentage per unit time
Rationale: First-order processes remove a fixed percentage per hour, so clearance
slows as levels fall; most psychotropics follow this pattern. Constant-amount removal
defines zero-order saturation kinetics.
Question 5. A highly lipophilic psychotropic with a large volume of distribution is:
A. Easily cleared by dialysis from the plasma
B. Unable to leave the bloodstream
C. Always safe in overdose without monitoring
D. Poorly removed by hemodialysis because most drug resides in tissues, not plasma
Correct Answer: D — Poorly removed by hemodialysis because most drug resides
in tissues, not plasma
Rationale: High tissue partitioning keeps plasma concentrations low, so dialysis
removes little drug in overdose. Dialyzability, blood confinement, and overdose safety
are false.
Question 6. The elimination half-life of a medication is the time required for:
A. Total body drug stores to fall to zero
B. The drug to reach its site of action
C. Plasma concentration to decrease by 50 percent
D. Absorption to begin in the small intestine
Correct Answer: C — Plasma concentration to decrease by 50 percent
Rationale: Half-life measures the 50 percent plasma decline used to time dosing and
predict steady state. Zero body burden, action-site delivery, and absorption onset
misstate the term.
, Question 7. A loading dose is prescribed for a medication with a long half-life in order to:
A. Reduce the total daily dose requirement permanently
B. Skip the maintenance phase entirely
C. Achieve therapeutic plasma concentrations rapidly rather than waiting several half-
lives
D. Eliminate the need for any monitoring
Correct Answer: C — Achieve therapeutic plasma concentrations rapidly rather
than waiting several half-lives
Rationale: A loading dose fills the volume of distribution so therapeutic levels appear
on day one, particularly valuable when the half-life is long. It does not replace
maintenance dosing or monitoring.
Question 8. A partial agonist at a receptor is distinguished by:
A. Producing the largest possible response at any occupancy
B. Blocking the receptor without any intrinsic activity
C. Accelerating receptor degradation permanently
D. Producing a submaximal response even when occupying all available receptors
Correct Answer: D — Producing a submaximal response even when occupying all
available receptors
Rationale: Partial agonists have intrinsic activity with a ceiling below full agonists,
improving safety in overdose or excess. Full agonist, pure antagonist, and degradative
labels misstate the pharmacology.
Question 9. Naloxone reverses opioid effects by acting as:
A. A full agonist that deepens sedation
B. A partial agonist with a high ceiling
C. A competitive antagonist that displaces agonists from mu receptors without intrinsic
activity
D. An enzyme that metabolizes all opioids instantly
Correct Answer: C — A competitive antagonist that displaces agonists from mu
receptors without intrinsic activity
Rationale: Naloxone competes for mu receptors, and its lack of intrinsic activity
reverses respiratory depression. Agonist and partial agonist labels reverse its action,
and it is not an enzyme.
Question 10. After months of continuous exposure to a receptor agonist, the typical
adaptive change is:
A. Upregulation and supersensitivity, amplifying the drug effect
B. Permanent destruction of the receptor gene
C. Downregulation or desensitization of receptors, reducing drug effect over time
D. No change whatsoever in receptor density
